MétaCan
Menu
← Back to cohort

Dexamethasone as a Novel Treatment for Obstructive Sleep Apnea in Children

2025· article· en· W4410273166 on OpenAlexaff
M. Terrance, J. Au, Siew Li Goh, Evan J. Propst, Nikolaus E. Wolter, Lena Xiao, Theo J. Moraes, I. Narang

Bibliographic record

VenueAmerican Journal of Respiratory and Critical Care Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicObstructive Sleep Apnea Research
Canadian institutionsBC Children's HospitalHospital for Sick Children
Fundersnot available
KeywordsMedicineDexamethasoneObstructive sleep apneaSleep apneaSleep (system call)Intensive care medicineInternal medicinePediatrics

Abstract

fetched live from OpenAlex

Abstract Rationale: Obstructive sleep apnea (OSA) is a sleep-related breathing disorder, characterized by upper airway obstruction. The first-line treatment for OSA is an adenotonsillectomy (AT), but there are long surgical wait times, leaving many children untreated and at high risk for long term health effects. OSA is also a chronic inflammatory condition that often presents with upper airway inflammation. However, oral anti-inflammatory treatments such as dexamethasone have not been fully explored.The purpose of this study is to evaluate the efficacy of dexamethasone in reducing the severity of moderate to severe OSA in children. Methods: This randomized, double-blinded, placebo-controlled trial compared a 3-day course of dexamethasone (0.5 mg/kg, max. 8 mg/day) to a placebo control in children between the ages of 2-10 years diagnosed with moderate to severe OSA (Obstructive apnea-hypopnea index (OAHI) ≥5). Overnight polysomnograms (PSGs), otolaryngology assessments, and questionnaires addressing OSA symptoms were conducted at baseline, 2 weeks and 6 months after the intervention. Primary outcome was the change in OAHI 2 weeks post-intervention. Results: Ten participants without surgical treatment of OSA were recruited: 5 received dexamethasone (3 male, median age: 4.0 years [IQR 2.5, 7.0]) and 5 received a placebo (1 male, median age: 4.0 years [IQR 2.5, 8.0]). Two weeks post intervention, there was no significant difference in the change in OAHI between the groups. The dexamethasone group had a median increase of 0.1 events/hour [IQR -7.2, 3.3], while the placebo group showed an increase of 2.1 events/hour [IQR 2.4, 8.5] (p=0.056). Within the dexamethasone group, 2 participants experienced a clinically significant 50% decrease in OAHI. No significant differences between the groups were found in changes in tonsil size and OSA symptom scores. At the 6-month follow-up, the initial reduction in OAHI in the dexamethasone group was not sustained, with median OAHI worsening compared to baseline (Baseline: 11.1 [IQR 8.7, 13.3]; 6 months post; 17.6 [IQR 9.3, 17.6]). Conclusions: Dexamethasone did not significantly reduce OAHI compared to placebo, though some participants showed a short-term response suggesting potential efficacy. Further studies in larger populations are needed before implementing in clinical practice.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.363
Teacher spread0.340 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of Respiratory and Critical Care Medicine→Same topicObstructive Sleep Apnea Research→French-language works237,207→